CUI Sufen, MA Min, HAN Xinning, YU Lin. Clinical analysis of intrauterine fetal death of singleton pregnancy[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 68-72. DOI: 10.7619/jcmp.20214587
Citation: CUI Sufen, MA Min, HAN Xinning, YU Lin. Clinical analysis of intrauterine fetal death of singleton pregnancy[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 68-72. DOI: 10.7619/jcmp.20214587

Clinical analysis of intrauterine fetal death of singleton pregnancy

More Information
  • Received Date: November 21, 2021
  • Available Online: May 09, 2022
  • Published Date: May 14, 2022
  •   Objective  To explore the high risk factors of intrauterine fetal death of singleton pregnancy.
      Methods  Clinical data of 79 singleton pregnancies with stillbirth delivered in Affiliated Hospital of Yangzhou University were analyzed retrospectively. The general situations (age, pregnancy and delivery times, gestational age, fetal movement, etc.), complications or comorbidity of pregnant women, placenta situation, umbilical cord situation, fetal situation and amniotic fluid volume were observed.
      Results  Except for unknown reasons (22/79, 27.9%), the high risk factors of stillbirth were umbilical cord factor (26/79, 32.9%), maternal factor (13/79, 16.5%), fetal abnormality (8/79, 10.1%), abnormal amniotic fluid volume (8/79, 10.1%), placenta factor (2/79, 2.5%). Stillbirth mainly occurred in late pregnancy caused by umbilical cord, and in the second trimester by fetal abnormalities and abnormal amniotic fluid volume, and the difference was statistically significant (P < 0.05). The proportion of stillbirths caused by maternal comorbidity or complications in the older pregnancy (aged ≥ 35 years) was higher than that in the age-appropriate group (aged 20 to 35 years), and the difference was statistically significant (P < 0.05).
      Conclusion  It is possible to reduce the incidence of stillbirth by the measures of strengthening the management of high-risk pregnant women, actively dealing with pregnancy complications and comorbidity, identifying the high-risk factors of stillbirth early and intervening, improving the diagnostic rate of excessive helix of umbilical cord and emphasizing the importance of fetal movement counting.
  • [1]
    谢幸, 孔北华, 段涛. 妇产科学[M]. 9版. 北京: 人民卫生出版社, 2018: 140-141.
    [2]
    马善朵. 胎死宫内的病因分析及治疗[J]. 临床医药文献电子杂志, 2019, 6(4): 75-76. https://www.cnki.com.cn/Article/CJFDTOTAL-LCWX201904050.htm
    [3]
    王爽, 杨慧霞. 17年间105例胎死宫内孕妇的临床分析[J]. 中华妇产科杂志, 2017, 52(12): 818-821.
    [4]
    许秀凤. 彩色多普勒超声检查对脐带扭转患者的临床价值[J]. 中外医疗, 2017, 36(16): 180-182. https://www.cnki.com.cn/Article/CJFDTOTAL-HZZZ201716065.htm
    [5]
    李锐锋, 欧惠仪, 谢聪, 等. 超声检查脐带过度扭转的意义[J]. 现代医用影像学, 2019, 28(7): 1466-1468, 1478. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYY201907003.htm
    [6]
    李雪艳, 于松. 超声监测孕11~14周脐带入口的临床价值[J]. 中国医疗设备, 2015, 30(8): 35-38. https://www.cnki.com.cn/Article/CJFDTOTAL-YLSX201508012.htm
    [7]
    LYKKE J A, LANGHOFF-ROOS J, SIBAI B M, et al. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother[J]. Hypertension, 2009, 53(6): 944-951. doi: 10.1161/HYPERTENSIONAHA.109.130765
    [8]
    何妍谊. 引起宫内死胎的相关因素及预防对策分析[J]. 世界复合医学, 2018, 4(4): 30-32, 98. https://www.cnki.com.cn/Article/CJFDTOTAL-SJFH201804010.htm
    [9]
    中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020)[J]. 中华妇产科杂志, 2020, 55(4): 227-238. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201510002.htm
    [10]
    XIONG T, MU Y, LIANG J, et al. Hypertensive disorders in pregnancy and stillbirth rates: a facility-based study in China[J]. Bull World Heal Organ, 2018, 96(8): 531-539. doi: 10.2471/BLT.18.208447
    [11]
    涂成城, 陶峰, 陈红波. 妊娠晚期胎死宫内高危因素分析及干预措施[J]. 实用妇科内分泌电子杂志, 2019, 6(18): 9-11, 28. https://www.cnki.com.cn/Article/CJFDTOTAL-FKDZ201918006.htm
    [12]
    ROLNIK D L, WRIGHT D, POON L C, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia[J]. N Engl J Med, 2017, 377(7): 613-622. doi: 10.1056/NEJMoa1704559
    [13]
    张海娟, 孙璐璐, 许艳蕾. 分娩期非瘢痕子宫自发性破裂一例[J]. 国际妇产科学杂志, 2021, 48(5): 532-534. https://www.cnki.com.cn/Article/CJFDTOTAL-GWVC202105014.htm
    [14]
    赫英东, 杨慧霞. 围产期瘢痕子宫破裂的早识别和早处理[J]. 中华围产医学杂志, 2016, 19(9): 649-652.
    [15]
    TAHSEEN S, GRIFFITHS M. Vaginal birth after two Caesarean sections (VBAC-2)-a systematic review with meta-analysis of success rate and adverse outcomes of VBAC-2 versus VBAC-1 and repeat (third) Caesarean sections[J]. BJOG Int J Obstet Gynaecol, 2010, 117(1): 5-19. doi: 10.1111/j.1471-0528.2009.02351.x
    [16]
    BIEBIGHAUSER K C, GAO J J, RAO P, et al. Non-seminomatous germ cell tumor with bone metastasis only at diagnosis: a rare clinical presentation[J]. Asian J Urol, 2017, 4(2): 124-127. doi: 10.1016/j.ajur.2016.08.004
    [17]
    江敏, 张春瑾, 瞿茜, 等. 妊娠期急性腹痛病人子宫破裂危险因素的Meta分析[J]. 循证护理, 2021, 7(6): 740-745. https://www.cnki.com.cn/Article/CJFDTOTAL-XZHL202106006.htm
    [18]
    单龙, 毛燕, 孙晓彤, 等. 不典型完全性子宫破裂5例临床分析并文献复习[J]. 中国计划生育和妇产科, 2021, 13(2): 75-79. https://www.cnki.com.cn/Article/CJFDTOTAL-JHFC202102021.htm
    [19]
    于娟娟. 妊娠晚期腹腔内出血2例报道[J]. 生殖医学杂志, 2021, 30(10): 1385-1387. https://www.cnki.com.cn/Article/CJFDTOTAL-SZYX202110024.htm
    [20]
    刘毅, 周辉, 胡茜. 妊娠期肝内胆汁淤积症发生死胎的临床分析[J]. 四川医学, 2013, 34(11): 1668-1670. https://www.cnki.com.cn/Article/CJFDTOTAL-SCYX201311022.htm
    [21]
    陈鹏, 刘兴会, 吴琳. 妊娠期肝内胆汁淤积症指南解读[J]. 实用妇产科杂志, 2019, 35(2): 103-105. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ201902010.htm
    [22]
    BURKMAN R T. Williams obstetrics[J]. JAMA J Am Med Assoc, 2010, 304(4): 474-475. doi: 10.1001/jama.2010.1039
    [23]
    HAN X, DU H Y, CAO Y L, et al. Association of histological and clinical chorioamnionitis with perinatal and neonatal outcome[J]. J Matern Fetal Neonatal Med, 2021, 34(5): 794-802. doi: 10.1080/14767058.2019.1618824
    [24]
    FENG B B, ZHAI J J, CAI Y. Effect of twin pregnancy chorionic properties on maternal and fetal outcomes[J]. Taiwan J Obstet Gynecol, 2018, 57(3): 351-354. doi: 10.1016/j.tjog.2018.03.002
  • Related Articles

    [1]FENG Lukun, SHI Yan, LI Dan, XU Yan. Influencing factors of poor prognosis after extracorporeal membrane oxygenation weaning in patients with cardiopulmonary arrest and the establishment of a nomogram prediction model[J]. Journal of Clinical Medicine in Practice, 2024, 28(15): 95-100. DOI: 10.7619/jcmp.20240486
    [2]WU Guohua, ZHANG Xiaofei, WANG Qi, LI Chao, YAN Xuefang. Relationships of carotid plaque characteristics and hemorheology with disease classification and severity in elderly patients with ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2024, 28(13): 58-62. DOI: 10.7619/jcmp.20240835
    [3]WAN Jiangwei, CHENG Dongru, WANG Tao, GAO Ping. Value of serum lactate dehydrogenase, β2 microglobulin and ferritin combined with modified WHO-based Prognostic Scoring System in predicting poor prognosis of myelodysplastic syndrome[J]. Journal of Clinical Medicine in Practice, 2024, 28(5): 79-84. DOI: 10.7619/jcmp.20233107
    [4]LI Ling, ZHU Lei, HOU Wen, WANG Zhuting, REN Xiaomei. Clinical characteristics and prognosis of prediabetic patients with cerebral hemorrhage[J]. Journal of Clinical Medicine in Practice, 2023, 27(5): 119-122, 127. DOI: 10.7619/jcmp.20223485
    [5]SHA Feiyan, CHEN Peipei, LI Wen, XIE Renbing. Values of CHA2DS2-VASc score and Global Registry of Acute Coronary Events risk score in predicting poor prognosis of patients with atrial fibrillation after percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2023, 27(3): 46-51. DOI: 10.7619/jcmp.20222276
    [6]YANG Ju, LI Xiaojing, LIU Xiuping, YANG Ke, CAO Li, SHU Weiqing. Expression of programmed cell death-ligand 1 of tumor-associated macrophages and its relationship with adverse prognosis of breast cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(13): 68-73, 78. DOI: 10.7619/jcmp.20220390
    [7]SUI Yong, SUN Hui, YAO Chuanwei, SHI Min, YU Jun. Serological predictors of poor prognosis in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2021, 25(21): 52-57. DOI: 10.7619/jcmp.20212165
    [8]WANG Jing, LIU Zhongzhong, LU Qingli, LIU Pei, LIU Yan, CHANG Qiaoqiao, ZHANG Na, LIN Xuemei, WANG Fang, WU Songdi. Analysis in clinical characteristics and 1-year prognosis of young and middle-aged as well as elderly patients with acute mild cerebral infarction in Xi'an area[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 34-38. DOI: 10.7619/jcmp.20201969
    [9]LIU Kebei. Clinical characteristics and prognosis of children with hyperpyretic convulsion[J]. Journal of Clinical Medicine in Practice, 2019, 23(16): 16-19. DOI: 10.7619/jcmp.201916005
    [10]ZHU Yaodong, ZHANG Mei, LI Ping. Clinical characteristics of varian cancer patients with survival time over 3 years and its influencing factors of prognosis[J]. Journal of Clinical Medicine in Practice, 2019, 23(9): 20-23. DOI: 10.7619/jcmp.201909006
  • Cited by

    Periodical cited type(8)

    1. 鲁志兵,李瑞娟,吴志清,肖永娟. 微小核糖核酸-451a在人参养荣汤治疗鼻咽癌放射性黏膜损伤中的机制研究. 临床医药实践. 2024(04): 243-247 .
    2. 罗红梅,王颖杰,李京辰,海丽娜. 复方苦参注射液治疗放射性肺损伤有效性的meta分析. 北京医学. 2024(05): 415-420 .
    3. 孙丕云,石彧,郭会,于鹏,梁艳艳,吴腾. 益气解毒利咽方灌胃对放射性唾液腺损伤小鼠的治疗作用及机制. 山东医药. 2024(22): 42-46 .
    4. 付小燕,王洪. 穴位揿针疗法对鼻咽癌患者化疗后恶心呕吐及生活质量的影响. 山西医药杂志. 2024(10): 775-778 .
    5. 杨玲. 复方苦参注射液治疗放疗所致口腔黏膜炎的有效性的Meta分析. 中国医院用药评价与分析. 2024(08): 995-998 .
    6. 孙蕊,李东芳. 黎月恒论治鼻咽癌临证经验. 中医药导报. 2023(02): 203-206+224 .
    7. 周义浪,田杰,朱国庆,吴晓勇,孙丽娥,徐静. 中医药在恶性肿瘤“全人群、全周期、全方位”管理中的应用与思考. 基层中医药. 2023(06): 19-24 .
    8. 张小云,山惠萍,奚兰花,冀胜军. 咀嚼运动联合穴位按摩在鼻咽癌放疗患者放射性口干症中的应用. 护理实践与研究. 2023(22): 3394-3399 .

    Other cited types(0)

Catalog

    Article views (188) PDF downloads (18) Cited by(8)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return